AEMD vs PATH · $2.5M cap vs P/E 19, rev $1.61B
Aethlon Medical Inc (AEMD) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Aethlon Medical Inc (AEMD) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AEMD revenue for 2024-03-31 was $0. Net income was -$12.2M. Revenue was down 100.0% from 2023-03-31 to 2024-03-31. AEMD currently screens at market cap $2.5M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AEMD currently screens at market cap $2.5M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AEMD and PATH stock pages for the full models.
Not investment advice.